Dongkuk Pharmaceutical achieved its largest quarterly revenue in history during the second quarter, according to MTNW advisor Bae Jun-ho. Market analysts note the company is undergoing a re-rating from a traditional pharmaceutical firm to a K-beauty growth stock, with cosmetic exports projected to surpass 1,000억 원 this year.
Dongkuk Pharmaceutical Leads K-Beauty Growth Stocks
Dongkuk Pharmaceutical reported record-breaking second-quarter sales figures, signaling a shift in market perception. According to MTNW advisor Bae Jun-ho, the company’s traditional pharmaceutical portfolio is now complemented by expanding cosmetic sales. Financial projections indicate that annual cosmetic exports will exceed 1,000억 원. Market participants have established a target price of 25,500 won with a stop-loss threshold set at 19,500 won.
Samsung SDI Secures Major Battery and ESS Contracts
Samsung SDI secured a new battery project order from Mercedes-Benz alongside a long-term supply agreement worth over 2조 won with an American energy storage system enterprise, according to MTNW advisor Seo Jae-hong. The industrial momentum highlights initiatives including cylindrical battery projects tailored for hybrid electric vehicles. Observers have outlined a target price of 700,000 won and a stop-loss mark of 518,000 won for the stock.
Bionia Advances Hair Loss Treatments and Clinical Research
Bionia is progressing with follow-up studies for its CosmeRNA product following the publication of human application test results for stress-related hair loss in an American academic journal, according to MTNW advisor Lim Kwang-bin. Global investment banks have characterized the treatment as a potential next-generation blockbuster. Market advisors have set a target price of 10,000 won alongside a stop-loss boundary of 7,900 won.
Market Summary of Featured Investment Targets
- Dongkuk Pharmaceutical: Second-quarter sales hit a record high; cosmetic exports projected above 1,000억 원; target price 25,500 won, stop-loss 19,500 won.
- Samsung SDI: Mercedes-Benz battery project win and US ESS contract; target price 700,000 won, stop-loss 518,000 won.
- Bionia: Stress-related hair loss study published in a US journal; target price 10,000 won, stop-loss 7,900 won.
Worth a look